Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Nutr ; 58(1): 113-130, 2019 Feb.
Article in English | MEDLINE | ID: mdl-29151137

ABSTRACT

PURPOSE: Epidemiological and intervention studies have attempted to link the health effects of a diet rich in fruits and vegetables with the consumption of polyphenols and their impact in neurodegenerative diseases. Studies have shown that polyphenols can cross the intestinal barrier and reach concentrations in the bloodstream able to exert effects in vivo. However, the effective uptake of polyphenols into the brain is still regarded with some reservations. Here we describe a combination of approaches to examine the putative transport of blackberry-digested polyphenols (BDP) across the blood-brain barrier (BBB) and ultimate evaluation of their neuroprotective effects. METHODS: BDP was obtained by in vitro digestion of blackberry extract and BDP major aglycones (hBDP) were obtained by enzymatic hydrolysis. Chemical characterization and BBB transport of extracts were evaluated by LC-MSn. BBB transport and cytoprotection of both extracts was assessed in HBMEC monolayers. Neuroprotective potential of BDP was assessed in NT2-derived 3D co-cultures of neurons and astrocytes and in primary mouse cerebellar granule cells. BDP-modulated genes were evaluated by microarray analysis. RESULTS: Components from BDP and hBDP were shown to be transported across the BBB. Physiologically relevant concentrations of both extracts were cytoprotective at endothelial level and BDP was neuroprotective in primary neurons and in an advanced 3D cell model. The major canonical pathways involved in the neuroprotective effect of BDP were unveiled, including mTOR signaling and the unfolded protein response pathway. Genes such as ASNS and ATF5 emerged as novel BDP-modulated targets. CONCLUSIONS: BBB transport of BDP and hBDP components reinforces the health benefits of a diet rich in polyphenols in neurodegenerative disorders. Our results suggest some novel pathways and genes that may be involved in the neuroprotective mechanism of the BDP polyphenol components.


Subject(s)
Blood-Brain Barrier/metabolism , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Polyphenols/pharmacology , Rubus/metabolism , Animals , Cells, Cultured , Chromatography, Liquid , Humans , In Vitro Techniques , Mass Spectrometry , Mice , Mice, Inbred BALB C , Models, Animal , Neuroprotective Agents/metabolism , Plant Extracts/metabolism , Polymerase Chain Reaction , Polyphenols/metabolism
2.
Nat Commun ; 9(1): 4857, 2018 11 19.
Article in English | MEDLINE | ID: mdl-30451842

ABSTRACT

Anthrax is an infectious disease caused by Bacillus anthracis, a bioterrorism agent that develops resistance to clinically used antibiotics. Therefore, alternative mechanisms of action remain a challenge. Herein, we disclose deoxy glycosides responsible for specific carbohydrate-phospholipid interactions, causing phosphatidylethanolamine lamellar-to-inverted hexagonal phase transition and acting over B. anthracis and Bacillus cereus as potent and selective bactericides. Biological studies of the synthesized compound series differing in the anomeric atom, glycone configuration and deoxygenation pattern show that the latter is indeed a key modulator of efficacy and selectivity. Biomolecular simulations show no tendency to pore formation, whereas differential metabolomics and genomics rule out proteins as targets. Complete bacteria cell death in 10 min and cellular envelope disruption corroborate an effect over lipid polymorphism. Biophysical approaches show monolayer and bilayer reorganization with fast and high permeabilizing activity toward phosphatidylethanolamine membranes. Absence of bacterial resistance further supports this mechanism, triggering innovation on membrane-targeting antimicrobials.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacillus anthracis/drug effects , Bacillus cereus/drug effects , Cell Membrane/drug effects , Cell Wall/drug effects , Glycosides/pharmacology , Phosphatidylethanolamines/antagonists & inhibitors , Bacillus anthracis/chemistry , Bacillus anthracis/growth & development , Bacillus anthracis/metabolism , Bacillus cereus/chemistry , Bacillus cereus/growth & development , Bacillus cereus/metabolism , Caco-2 Cells , Carbohydrate Conformation , Cell Membrane/chemistry , Cell Membrane/metabolism , Cell Survival/drug effects , Cell Wall/chemistry , Cell Wall/metabolism , Humans , Kinetics , Lipid Bilayers/chemistry , Lipid Bilayers/metabolism , Microbial Sensitivity Tests , Microbial Viability/drug effects , Phase Transition , Phosphatidylethanolamines/chemistry , Phosphatidylethanolamines/metabolism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...